Details for New Drug Application (NDA): 081095
✉ Email this page to a colleague
NDA 081095 describes ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, which is a drug marketed by Mikart and is included in three NDAs. Additional details are available on the ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE profile page.
The generic ingredient in ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.
The generic ingredient in ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.
Summary for 081095
| Tradename: | ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE |
| Applicant: | Mikart |
| Ingredient: | acetaminophen; aspirin; codeine phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 150MG;180MG;15MG | ||||
| Approval Date: | Oct 26, 1990 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
